Michael Farrell, MD
Urology · Columbus, OHNPI 1023499415
Payments from drug & device makers
What this record shows
This record is dominated by grants: $50,000 of the $51,573 with a category attached, or 96.9%. Boston Scientific accounts for 98.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $50,219 and has fallen 99.9% since, to $27 in 2025. Among urology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 22 payments — averaging $2344.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$51K
- Teleflex LLC$263
- Abbott$143
- Coloplast$52
- AstraZeneca$46
- Laborie Medical Technologies Corp.$43
- plus $30 from 1 others
What the payments were for
- Grants$50,00097%
- Food & beverage$1,5733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $50,997 |
| Teleflex LLC | 3 | $263 |
| Abbott | 1 | $143 |
| Coloplast | 1 | $52 |
| AstraZeneca | 1 | $46 |
| Laborie Medical Technologies Corp. | 2 | $43 |
| Myovant Sciences Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL ERECTILE DYSFUNCTION$50,000
- GENERAL - THERAPIES$302
- AMS 800 Artificial Urinary Sphincter$284
- PROCLAIM$143
- CLINICAL T$134
- UroLift System$122
- UroLift$117
How this compares
$51,573 in reported general payments places this provider in the 90th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 15 | $11,036 |
| Methenamine Hippurate | 35 | $2,617 |
| Trospium Chloride | 30 | $1,890 |
| Silodosin | 23 | $1,056 |
| Clobetasol Propionate | 28 | $647 |
| Tamsulosin Hcl | 111 | $606 |
| Cephalexin | 24 | $112 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $110 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $110 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $52 |
| Finasteride | 25 | $19 |
Paid to pharmacies, not to this prescriber.
Other urology in Columbus
- Bodo KnudsenColumbus$108K
- Gregory LoweColumbus$106K
- George HoColumbus$72K
- Hiren PatelColumbus$54K
- Nicholas TadrosColumbus$32K
- Eric RiedingerColumbus$27K
- Eric SingerColumbus$25K
- Cheryl LeeColumbus$22K
- Matthew LeeColumbus$16K
- Lawrence GervasiMiddleburg Heights$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.